New hope for heart failure: drug may boost Life-Saving treatment
NCT ID NCT07576257
First seen May 09, 2026 · Last updated May 20, 2026 · Updated 4 times
Summary
This study tests if a drug called sodium zirconium cyclosilicate (SZC) can help people with heart failure stay on higher, more effective doses of a standard medication (MRA). About 110 adults over 70 with heart failure will take SZC or a placebo for 6 months. The goal is to see if SZC allows more patients to maintain the higher MRA dose, potentially improving heart failure control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.